1. D-dimer can help differentiate suspected pulmonary embolism patients that require anti-coagulation
- Author
-
Jatin Narang, Philip R. Wang, Spencer S. Seballos, Amy S. Nowacki, and Sharon E. Mace
- Subjects
Male ,medicine.medical_specialty ,Decision Making ,VTE, venous thromboembolism ,Suspected pulmonary embolism ,Anti coagulation ,PE, Pulmonary embolism ,CTPA, computed pulmonary tomography angiography ,Article ,Fibrin Fibrinogen Degradation Products ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,D-dimer ,Humans ,Medicine ,Retrospective Studies ,Receiver operating characteristic ,DVT, deep vein thrombosis ,DOAC, direct oral anti-coagulant ,business.industry ,Age Factors ,Curve analysis ,Area under the curve ,Anticoagulants ,030208 emergency & critical care medicine ,Anti-coagulation ,General Medicine ,Middle Aged ,ACCP, American College of Chest Physicians ,medicine.disease ,LMWH, low molecular weight heparin ,Pulmonary embolism ,medicine.anatomical_structure ,V/Q scan, perfusion ventilation scan ,Emergency Medicine ,Cardiology ,Female ,Emergency Service, Hospital ,Pulmonary Embolism ,business ,Biomarkers ,Venous thromboembolism ,Artery - Abstract
Objectives Determine whether D-dimer concentration in the absence of imaging can differentiate patients that require anti-coagulation from patients who do not require anti-coagulation. Methods Data was obtained retrospectively from 366 hemodynamically stable adult ED patients with suspected pulmonary embolism (PE). Patients were categorized by largest occluded artery and aggregated into: ‘Require anti-coagulation’ (main, lobar, and segmental PE), ‘Does not require anti-coagulation’ (sub-segmental and No PE), ‘High risk of deterioration’ (main and lobar PE), and ‘Not high risk of deterioration’ (segmental, sub-segmental, and No PE) groups. Wilcoxon rank-sum test was used for 2 sample comparisons of median D-dimer concentrations. Receiver operating characteristic (ROC) curve analysis was utilized to determine a D-dimer cut-off that could differentiate ‘Require anti-coagulation’ from ‘Does not require anti-coagulation’ and ‘High risk of deterioration’ from ‘Low risk of deterioration’ groups. Results The ‘Require anti-coagulation’ group had a maximum area under the curve (AUC) of 0.92 at an age-adjusted D-dimer cut-off of 1540 with a specificity of 86% (95% CI, 81–91%), and sensitivity of 84% (79–90%). The ‘High risk of deterioration’ group had a maximum AUC of 0.93 at an age-adjusted D-dimer cut-off of 2500 with a specificity of 90% (85–93%) and sensitivity of 83% (77–90%). Conclusions An age-adjusted D-dimer cut-off of 1540 ng/mL differentiates suspected PE patients requiring anti-coagulation from those not requiring anti-coagulation. A cut-off of 2500 differentiates those with high risk of clinical deterioration from those not at high risk of deterioration. When correlated with clinical outcomes, these cut-offs can provide an objective method for clinical decision making when imaging is unavailable., Highlights • ED providers are faced with risks and benefits when empirically administering anti-coagulation for suspected PE patients. • We show that D-dimer concentration can be used as a clinical decision making tool to minimize these risks. • A D-dimer cut-off of 1540 ng/mL can be used to minimize unnecessary anti-coagulation exposure in patients who do not need it. • A D-dimer cut-off of 2500 ng/mL can be used to minimize risk of withholding treatment for patients at risk of clinical deterioration. • Together these cut-offs provide an objective measure that can be combined with clinical gestalt to weight the risks and benefits of empiric anti-coagulation.
- Published
- 2021